1. Tofacitinib for the treatment of severe rare skin diseases: a narrative review

   • Fenglin Luo
   • Yuanyuan Zhang
   • Ping Wang

   Review 17 January 2024 Pages: 481 - 492

2. Remimazolam versus propofol for sedation in gastrointestinal endoscopy and colonoscopy within elderly patients: a meta-analysis of randomized controlled trials

   • Wania Ahmer
   • Sahar Imtiaz
   • Muhammad Omar Larik

   Review 23 January 2024 Pages: 493 - 503

   

3. Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis

   • Zhuchen Yu
   • Fei Xu
   • Juntao Zou

   Review 01 February 2024 Pages: 505 - 517

   

4. The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer

   • Ruggero Lasala
   • Alessia Romagnoli
   • Felice Musicco

   Research 20 January 2024 Pages: 519 - 527

   

5. Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation

   • Shampa Das
   • Todd Riccobene
   • Susan Raber

   Research Open access 22 January 2024 Pages: 529 - 543

   

6. Cardiovascular medications used for comorbid diseases in patients with atrial fibrillation. The JoFib study

   • Nasr Alrabadi
   • Mohammed Al-Nusair
   • Ayman Hamoudeh

   Research 23 January 2024 Pages: 545 - 552

7. Patterns of inappropriate prescribing and clinical characteristics in patients at admission to an acute care of the elderly unit

   • Mónica Zuleta
   • Antonio San-José
   • Carmen Pérez-Bocanegra

   Research 24 January 2024 Pages: 553 - 561

8. The relationship between use of SGLT2is and incidence of respiratory and infectious diseases and site-specific fractures: a meta-analysis based on 32 large RCTs

   • Yueping Wang
   • Xian Zhou

   Research 25 January 2024 Pages: 563 - 573

   

9. Estimating the impact of label design on reducing the risk of medication errors by applying HEART in drug administration

   • Carlos Aceves-Gonzalez
   • Angela Caro-Rojas
   • Karen Hernández-Cruz

   Research Open access 29 January 2024 Pages: 575 - 588

   

10. Dabigatran-related serious medication errors: an analysis using data from VigiBase

    • Qingxia Zhang
    • Qian Ding
    • Qun-Ying Yue

    Research Open access 29 January 2024 Pages: 589 - 595

11. Association of the predicted free blood concentration of teicoplanin with the development of renal dysfunction

    • Kyohei Sugiyama
    • Keita Hirai
    • Kenta Ito

    Research 29 January 2024 Pages: 597 - 602

    

12. Comparing AGS Beers 2019, STOPP version 2, and EU(7)-PIM list in Portuguese older adults in primary health care

    • Daniela A. Rodrigues
    • Maria Teresa Herdeiro
    • Fátima Roque

    Research Open access 06 February 2024 Pages: 603 - 612

    

13. Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients

    • Dabei Cai
    • Qianwen Chen
    • Ling Sun

    Research Open access 06 February 2024 Pages: 613 - 620

    

14. Comment on “Risk of gastric cancer among long‑term proton pump inhibitor users: a population‑based cohort study”

    • Shih-Wei Lai
    • Bing-Fang Hwang
    • Kuan-Fu Liao

    Correspondence 31 January 2024 Pages: 621 - 622

    

15. Retraction Note: Graphical representation of network meta-analysis: an iconographic support to the complexity of multiple data comparisons

    • Renato De Vecchis
    • Carmelina Ariano
    • Michel Noutsias

    Retraction Note 10 February 2024 Pages: 623 - 623